Glycoprotein News and Research

RSS
Rubella antibodies vs. COVID-19

Rubella antibodies vs. COVID-19

Molecular dynamic simulations unveil conformational dynamics of SARS-CoV-2 spike protein RBD and ACE2 receptor

Molecular dynamic simulations unveil conformational dynamics of SARS-CoV-2 spike protein RBD and ACE2 receptor

Using CRISPR/Cas to develop biosafety materials

Using CRISPR/Cas to develop biosafety materials

Study unveils several natural marine products as potential agents against SARS-CoV-2

Study unveils several natural marine products as potential agents against SARS-CoV-2

Huddersfield researchers demonstrate how coronavirus activates the brain's immune response

Huddersfield researchers demonstrate how coronavirus activates the brain's immune response

Two clever human antibodies can target Ebola and Sudan virus

Two clever human antibodies can target Ebola and Sudan virus

Evaluating vesicular stomatitis virus-based COVID-19 vaccines against SARS-CoV-2 variants in hamsters

Evaluating vesicular stomatitis virus-based COVID-19 vaccines against SARS-CoV-2 variants in hamsters

Study reports thiopurines inhibit the replication of the betacoronaviruses HCoV-OC43 and SARS-CoV-2

Study reports thiopurines inhibit the replication of the betacoronaviruses HCoV-OC43 and SARS-CoV-2

Nanoparticle-enhanced phototherapies for cancer treatment

Nanoparticle-enhanced phototherapies for cancer treatment

Sustainable material-based biosensors for SARS-CoV-2 detection

Sustainable material-based biosensors for SARS-CoV-2 detection

In silico screening and testing of FDA approved drugs inhibiting SARS-CoV-2 spike protein cleavage

In silico screening and testing of FDA approved drugs inhibiting SARS-CoV-2 spike protein cleavage

Study indicates a 100 µg mRNA-1273 booster has acceptable safety and robust antibody response against SARS-CoV-2

Study indicates a 100 µg mRNA-1273 booster has acceptable safety and robust antibody response against SARS-CoV-2

Potent pan-β-CoV human monoclonal antibody has in vivo activity in multiple animal models

Potent pan-β-CoV human monoclonal antibody has in vivo activity in multiple animal models

Engineered SARS-CoV-2 immunogens elicit broadly neutralizing antibodies

Engineered SARS-CoV-2 immunogens elicit broadly neutralizing antibodies

Study reveals differential blood glycoprotein profiles in symptomatic and asymptomatic COVID-19 patients

Study reveals differential blood glycoprotein profiles in symptomatic and asymptomatic COVID-19 patients

Study suggests recent common cold may actually lead to worse COVID-19 disease

Study suggests recent common cold may actually lead to worse COVID-19 disease

Severity-dependent immune mechanisms in the cerebrospinal fluid and plasma of COVID-19 patients

Severity-dependent immune mechanisms in the cerebrospinal fluid and plasma of COVID-19 patients

Identifying and managing drug-drug interactions key to the safe use of nirmatrelvir–ritonavir in COVID-19 treatment

Identifying and managing drug-drug interactions key to the safe use of nirmatrelvir–ritonavir in COVID-19 treatment

Research uncovers a new molecular interaction mechanism for SARS-CoV2

Research uncovers a new molecular interaction mechanism for SARS-CoV2

Cow's milk protein can trigger inflammation in multiple sclerosis sufferers

Cow's milk protein can trigger inflammation in multiple sclerosis sufferers